

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.52142862 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49054919 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49054919 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.49054919 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49054919 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.49054919 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49054919 |
| 8 | response to peptidoglycan (GO:0032494) | 5.21215240 |
| 9 | respiratory burst (GO:0045730) | 5.14037384 |
| 10 | cellular extravasation (GO:0045123) | 4.95554128 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66566817 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39515512 |
| 13 | myeloid cell activation involved in immune response (GO:0002275) | 4.33776239 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.28443654 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.28443654 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.28443654 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.26404828 |
| 18 | mast cell activation (GO:0045576) | 4.24455236 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.22332786 |
| 20 | response to muramyl dipeptide (GO:0032495) | 4.14542374 |
| 21 | T cell migration (GO:0072678) | 4.02292026 |
| 22 | L-fucose catabolic process (GO:0042355) | 4.02273952 |
| 23 | fucose catabolic process (GO:0019317) | 4.02273952 |
| 24 | L-fucose metabolic process (GO:0042354) | 4.02273952 |
| 25 | DNA deamination (GO:0045006) | 3.92060789 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 3.90337963 |
| 27 | granulocyte activation (GO:0036230) | 3.89886913 |
| 28 | leukocyte degranulation (GO:0043299) | 3.89123947 |
| 29 | neutrophil activation (GO:0042119) | 3.83941799 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81178548 |
| 31 | microglial cell activation (GO:0001774) | 3.75701091 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.74372509 |
| 33 | response to host immune response (GO:0052572) | 3.74372509 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.71728384 |
| 35 | tryptophan metabolic process (GO:0006568) | 3.69049113 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.68458526 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65073102 |
| 38 | mast cell activation involved in immune response (GO:0002279) | 3.63136035 |
| 39 | mast cell degranulation (GO:0043303) | 3.63136035 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 3.61433302 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.58241879 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.54740692 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.54740692 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.53857371 |
| 45 | cellular response to exogenous dsRNA (GO:0071360) | 3.51534270 |
| 46 | response to type I interferon (GO:0034340) | 3.50467738 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44673956 |
| 48 | positive regulation of defense response to virus by host (GO:0002230) | 3.41927748 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.41401558 |
| 50 | behavioral response to nicotine (GO:0035095) | 3.41005744 |
| 51 | lymphocyte chemotaxis (GO:0048247) | 3.40607145 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.40436318 |
| 53 | defense response to protozoan (GO:0042832) | 3.38545567 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36252138 |
| 55 | neutrophil mediated immunity (GO:0002446) | 3.35122365 |
| 56 | germinal center formation (GO:0002467) | 3.34107834 |
| 57 | response to host (GO:0075136) | 3.33230012 |
| 58 | response to host defenses (GO:0052200) | 3.33230012 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.33230012 |
| 60 | positive regulation of interferon-beta production (GO:0032728) | 3.30151722 |
| 61 | NAD biosynthetic process (GO:0009435) | 3.29954552 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.29938253 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27540985 |
| 64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.27540985 |
| 65 | pinocytosis (GO:0006907) | 3.26620224 |
| 66 | leukocyte aggregation (GO:0070486) | 3.26312439 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 3.25316615 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.25011517 |
| 69 | superoxide anion generation (GO:0042554) | 3.22615387 |
| 70 | response to interferon-beta (GO:0035456) | 3.22502327 |
| 71 | response to protozoan (GO:0001562) | 3.20978211 |
| 72 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19212187 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 3.16985313 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14405207 |
| 75 | macrophage activation (GO:0042116) | 3.14025920 |
| 76 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.13127399 |
| 77 | B cell mediated immunity (GO:0019724) | 3.12396865 |
| 78 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10123981 |
| 79 | natural killer cell mediated immunity (GO:0002228) | 3.10123981 |
| 80 | regulation of B cell differentiation (GO:0045577) | 3.09442417 |
| 81 | negative regulation of interleukin-1 production (GO:0032692) | 3.09166394 |
| 82 | response to interferon-alpha (GO:0035455) | 3.08856448 |
| 83 | cellular response to interferon-beta (GO:0035458) | 3.08013528 |
| 84 | myeloid leukocyte activation (GO:0002274) | 3.07466388 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04107592 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.03779803 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.02023470 |
| 88 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02023470 |
| 89 | mature B cell differentiation (GO:0002335) | 3.01840025 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.00141601 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99666823 |
| 92 | negative regulation of mast cell activation (GO:0033004) | 2.99600312 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.98007470 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 2.96738255 |
| 95 | amine catabolic process (GO:0009310) | 2.96738255 |
| 96 | leukocyte mediated cytotoxicity (GO:0001909) | 2.96598937 |
| 97 | detection of other organism (GO:0098543) | 2.95390353 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94974755 |
| 99 | T-helper 1 type immune response (GO:0042088) | 2.93707240 |
| 100 | cytidine deamination (GO:0009972) | 2.93499804 |
| 101 | cytidine metabolic process (GO:0046087) | 2.93499804 |
| 102 | cytidine catabolic process (GO:0006216) | 2.93499804 |
| 103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92653811 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92636990 |
| 105 | B cell receptor signaling pathway (GO:0050853) | 2.90552387 |
| 106 | negative regulation of viral genome replication (GO:0045071) | 2.83504596 |
| 107 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82771893 |
| 108 | negative regulation of cell killing (GO:0031342) | 2.79947406 |
| 109 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79947406 |
| 110 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.79556133 |
| 111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79016696 |
| 112 | cellular ketone body metabolic process (GO:0046950) | 2.77937754 |
| 113 | regulation of interleukin-17 production (GO:0032660) | 2.77377820 |
| 114 | activated T cell proliferation (GO:0050798) | 2.76811938 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 2.76272650 |
| 116 | alkaloid metabolic process (GO:0009820) | 2.76222084 |
| 117 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.75065167 |
| 118 | eosinophil chemotaxis (GO:0048245) | 2.74949589 |
| 119 | neutrophil chemotaxis (GO:0030593) | 2.74277110 |
| 120 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73232468 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71963994 |
| 122 | detection of bacterium (GO:0016045) | 2.71704786 |
| 123 | positive regulation of interleukin-17 production (GO:0032740) | 2.68616815 |
| 124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.68129613 |
| 125 | regulation of mononuclear cell migration (GO:0071675) | 2.67865836 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67668244 |
| 127 | neutrophil migration (GO:1990266) | 2.66865960 |
| 128 | lymphocyte mediated immunity (GO:0002449) | 2.66862193 |
| 129 | fucosylation (GO:0036065) | 2.64279750 |
| 130 | regulation of defense response to virus by host (GO:0050691) | 2.63199762 |
| 131 | aromatic amino acid family catabolic process (GO:0009074) | 2.62883730 |
| 132 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.62549440 |
| 133 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.62549440 |
| 134 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.60749310 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.59824434 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.59791427 |
| 137 | sulfation (GO:0051923) | 2.59302438 |
| 138 | drug catabolic process (GO:0042737) | 2.58179122 |
| 139 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.57377568 |
| 140 | positive regulation of fatty acid transport (GO:2000193) | 2.56800405 |
| 141 | oxidative demethylation (GO:0070989) | 2.53817551 |
| 142 | negative T cell selection (GO:0043383) | 2.52255496 |
| 143 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.51594655 |
| 144 | ketone body metabolic process (GO:1902224) | 2.49595945 |
| 145 | positive regulation of prostaglandin secretion (GO:0032308) | 2.47018158 |
| 146 | reactive oxygen species biosynthetic process (GO:1903409) | 2.46219263 |
| 147 | negative regulation of innate immune response (GO:0045824) | 2.44463652 |
| 148 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.43960071 |
| 149 | detection of light stimulus involved in visual perception (GO:0050908) | 2.43960071 |
| 150 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.43757652 |
| 151 | tolerance induction (GO:0002507) | 2.42982395 |
| 152 | negative thymic T cell selection (GO:0045060) | 2.38936352 |
| 153 | indole-containing compound metabolic process (GO:0042430) | 2.38751247 |
| 154 | cellular response to interleukin-15 (GO:0071350) | 2.38241576 |
| 155 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.37775315 |
| 156 | mannosylation (GO:0097502) | 2.37644902 |
| 157 | positive regulation of icosanoid secretion (GO:0032305) | 2.36126037 |
| 158 | negative regulation of telomere maintenance (GO:0032205) | 2.34370226 |
| 159 | adaptation of signaling pathway (GO:0023058) | 2.34352218 |
| 160 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.33271556 |
| 161 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.32517439 |
| 162 | cytokine biosynthetic process (GO:0042089) | 2.31244691 |
| 163 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.29307594 |
| 164 | interferon-gamma production (GO:0032609) | 2.29215918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.91952586 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.85434283 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.56607838 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.99269012 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.99181201 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.95987531 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68410880 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42944311 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41081919 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21544099 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.16434301 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.08383338 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95908525 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93777559 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87580111 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69974878 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.63804944 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41737762 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39666607 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36855051 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32304508 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28378113 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18668763 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12608480 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02929371 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01094624 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96749196 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95041676 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86313635 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85975810 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85326972 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80634931 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80119536 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79506829 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77104633 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76843491 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.75542426 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.74816330 |
| 39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.74542608 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.74109737 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.72949284 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65516129 |
| 43 | ERA_21632823_ChIP-Seq_H3396_Human | 1.63739877 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.63395720 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61862311 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61832712 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58242622 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57761891 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51769296 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50265380 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49984279 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49142936 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48882761 |
| 54 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.48029987 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.47380059 |
| 56 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.47216341 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44142119 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43209220 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42470946 |
| 60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.42355725 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.41462971 |
| 62 | P300_27268052_Chip-Seq_Bcells_Human | 1.41424396 |
| 63 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.40538724 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39883089 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39715885 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39118679 |
| 67 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.38622428 |
| 68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.37084951 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36127858 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34237551 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32155212 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.31423937 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30964734 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29813166 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.28521366 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27330388 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26225247 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.25238953 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24066989 |
| 80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.23726405 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22694717 |
| 82 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22561414 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21007409 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 1.20922878 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20794254 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20661664 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20282589 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.20099568 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17782733 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17355956 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17253408 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17253408 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17253408 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16310716 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15992196 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15992196 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14010561 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12780652 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12588818 |
| 100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.11770533 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11702238 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11260594 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09266769 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09251236 |
| 105 | P68_20966046_ChIP-Seq_HELA_Human | 1.09217119 |
| 106 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09056083 |
| 107 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.07065202 |
| 108 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06497065 |
| 109 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06043319 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.03905148 |
| 111 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.03878074 |
| 112 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03385902 |
| 113 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03028748 |
| 114 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02684481 |
| 115 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02584388 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01984021 |
| 117 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01880892 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01255269 |
| 119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00614739 |
| 120 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.00156065 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99428553 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99327829 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98855230 |
| 124 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.98779447 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98639852 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98476793 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93655441 |
| 128 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93581012 |
| 129 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93212539 |
| 130 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92190378 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91727237 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91535038 |
| 133 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87643655 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85786997 |
| 135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85193621 |
| 136 | MYC_22102868_ChIP-Seq_BL_Human | 0.85018336 |
| 137 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.77012305 |
| 138 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75323406 |
| 139 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74182331 |
| 140 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.74092671 |
| 141 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73238111 |
| 142 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.72606329 |
| 143 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72591407 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71672340 |
| 145 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.69551685 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68076171 |
| 147 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.67870559 |
| 148 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66436934 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66170783 |
| 150 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.65900632 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.65888319 |
| 152 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.64215678 |
| 153 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63770597 |
| 154 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.62985590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.97540360 |
| 2 | MP0003436_decreased_susceptibility_to | 3.76229860 |
| 3 | MP0009785_altered_susceptibility_to | 3.47919378 |
| 4 | * MP0005058_abnormal_lysosome_morphology | 3.33792610 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.19895042 |
| 6 | MP0002419_abnormal_innate_immunity | 3.18373798 |
| 7 | MP0006082_CNS_inflammation | 3.06248378 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.00666117 |
| 9 | MP0005025_abnormal_response_to | 2.99099291 |
| 10 | MP0003195_calcinosis | 2.90461380 |
| 11 | MP0003724_increased_susceptibility_to | 2.84930120 |
| 12 | MP0005671_abnormal_response_to | 2.79796414 |
| 13 | MP0001800_abnormal_humoral_immune | 2.75140184 |
| 14 | MP0000685_abnormal_immune_system | 2.74959364 |
| 15 | MP0001790_abnormal_immune_system | 2.73191454 |
| 16 | MP0005387_immune_system_phenotype | 2.73191454 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.70710213 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.67810017 |
| 19 | MP0002723_abnormal_immune_serum | 2.62814976 |
| 20 | MP0001819_abnormal_immune_cell | 2.39969719 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.37804629 |
| 22 | MP0003303_peritoneal_inflammation | 2.35328116 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.31261701 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.16307968 |
| 25 | MP0009278_abnormal_bone_marrow | 2.07606102 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.97741925 |
| 27 | MP0009840_abnormal_foam_cell | 1.96475571 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.96180849 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.96169180 |
| 30 | MP0002405_respiratory_system_inflammati | 1.95126002 |
| 31 | MP0004947_skin_inflammation | 1.93651944 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.92103646 |
| 33 | MP0005365_abnormal_bile_salt | 1.89590730 |
| 34 | MP0001853_heart_inflammation | 1.80874063 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.80673140 |
| 36 | MP0000716_abnormal_immune_system | 1.80128965 |
| 37 | MP0002398_abnormal_bone_marrow | 1.79968522 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.77429279 |
| 39 | MP0004510_myositis | 1.77387554 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.76414080 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.75953231 |
| 42 | MP0008260_abnormal_autophagy | 1.74191667 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.70292306 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.68799027 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.67824335 |
| 46 | MP0003646_muscle_fatigue | 1.67657536 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.63824861 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.63522797 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.63522797 |
| 50 | MP0008469_abnormal_protein_level | 1.60252485 |
| 51 | MP0004043_abnormal_pH_regulation | 1.58938745 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.57401281 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.54788828 |
| 54 | MP0003878_abnormal_ear_physiology | 1.54788828 |
| 55 | MP0002722_abnormal_immune_system | 1.51824195 |
| 56 | MP0003136_yellow_coat_color | 1.51444455 |
| 57 | MP0002429_abnormal_blood_cell | 1.50713997 |
| 58 | MP0008872_abnormal_physiological_respon | 1.47368838 |
| 59 | MP0000343_altered_response_to | 1.45610502 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.44318952 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.44090632 |
| 62 | MP0005360_urolithiasis | 1.40243128 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.37471980 |
| 64 | MP0010329_abnormal_lipoprotein_level | 1.37380113 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.35823911 |
| 66 | MP0003448_altered_tumor_morphology | 1.34531560 |
| 67 | MP0009764_decreased_sensitivity_to | 1.30783029 |
| 68 | MP0001851_eye_inflammation | 1.29456239 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.29274644 |
| 70 | MP0003075_altered_response_to | 1.27486259 |
| 71 | MP0001663_abnormal_digestive_system | 1.19869761 |
| 72 | MP0005310_abnormal_salivary_gland | 1.19830212 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.18202583 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.16481117 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.14891891 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.14323226 |
| 77 | MP0003690_abnormal_glial_cell | 1.13480886 |
| 78 | MP0000858_altered_metastatic_potential | 1.13001257 |
| 79 | MP0001501_abnormal_sleep_pattern | 1.12816850 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.11793112 |
| 81 | MP0002006_tumorigenesis | 1.10404944 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.08787857 |
| 83 | MP0002933_joint_inflammation | 1.07885463 |
| 84 | MP0003011_delayed_dark_adaptation | 1.06773176 |
| 85 | MP0004142_abnormal_muscle_tone | 1.06168784 |
| 86 | MP0009763_increased_sensitivity_to | 1.05857781 |
| 87 | MP0000490_abnormal_crypts_of | 1.04404161 |
| 88 | MP0001873_stomach_inflammation | 1.04196670 |
| 89 | MP0000604_amyloidosis | 1.03229976 |
| 90 | MP0000703_abnormal_thymus_morphology | 1.03145778 |
| 91 | MP0001968_abnormal_touch/_nociception | 1.01993973 |
| 92 | MP0000427_abnormal_hair_cycle | 1.01600077 |
| 93 | MP0003252_abnormal_bile_duct | 1.00447697 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.99308566 |
| 95 | MP0003828_pulmonary_edema | 0.98220634 |
| 96 | MP0000371_diluted_coat_color | 0.97134098 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.95125218 |
| 98 | MP0010307_abnormal_tumor_latency | 0.94108849 |
| 99 | MP0005083_abnormal_biliary_tract | 0.92500916 |
| 100 | MP0003866_abnormal_defecation | 0.92399777 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.92366166 |
| 102 | MP0005390_skeleton_phenotype | 0.91387052 |
| 103 | MP0001919_abnormal_reproductive_system | 0.91233455 |
| 104 | MP0005332_abnormal_amino_acid | 0.89725385 |
| 105 | MP0002102_abnormal_ear_morphology | 0.89188001 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.89043157 |
| 107 | MP0004381_abnormal_hair_follicle | 0.86404373 |
| 108 | MP0000470_abnormal_stomach_morphology | 0.86099968 |
| 109 | MP0002254_reproductive_system_inflammat | 0.83623087 |
| 110 | MP0005166_decreased_susceptibility_to | 0.83568537 |
| 111 | MP0000920_abnormal_myelination | 0.82722373 |
| 112 | MP0004130_abnormal_muscle_cell | 0.81298846 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.81296490 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.80877832 |
| 115 | MP0003300_gastrointestinal_ulcer | 0.80358578 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.80178491 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.76992557 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.76834510 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.75679189 |
| 120 | MP0005448_abnormal_energy_balance | 0.74814281 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.74654102 |
| 122 | MP0001664_abnormal_digestion | 0.73684302 |
| 123 | MP0004147_increased_porphyrin_level | 0.73623784 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.72940747 |
| 125 | MP0002132_abnormal_respiratory_system | 0.71513491 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.70325894 |
| 127 | MP0005164_abnormal_response_to | 0.67100774 |
| 128 | MP0008057_abnormal_DNA_replication | 0.65766124 |
| 129 | MP0002095_abnormal_skin_pigmentation | 0.63968501 |
| 130 | MP0000249_abnormal_blood_vessel | 0.63083168 |
| 131 | MP0003186_abnormal_redox_activity | 0.62484333 |
| 132 | MP0003566_abnormal_cell_adhesion | 0.60790653 |
| 133 | MP0003795_abnormal_bone_structure | 0.60117391 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.59203486 |
| 135 | MP0002019_abnormal_tumor_incidence | 0.58396557 |
| 136 | MP0005451_abnormal_body_composition | 0.58289211 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.58030532 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.57787006 |
| 139 | MP0003045_fibrosis | 0.56483340 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.55527606 |
| 141 | MP0001986_abnormal_taste_sensitivity | 0.55469989 |
| 142 | MP0001764_abnormal_homeostasis | 0.54351469 |
| 143 | MP0002138_abnormal_hepatobiliary_system | 0.53422081 |
| 144 | MP0000367_abnormal_coat/_hair | 0.52917800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.29948273 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.75536351 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.24275383 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.21203802 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.78266122 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.72768044 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38326797 |
| 8 | Recurrent skin infections (HP:0001581) | 4.22746244 |
| 9 | Prostate neoplasm (HP:0100787) | 4.22257522 |
| 10 | Stomatitis (HP:0010280) | 4.19910694 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.03287138 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.00445323 |
| 13 | Obstructive lung disease (HP:0006536) | 4.00445323 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.86402629 |
| 15 | Myositis (HP:0100614) | 3.83699643 |
| 16 | Pustule (HP:0200039) | 3.82169323 |
| 17 | * Vacuolated lymphocytes (HP:0001922) | 3.77752400 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.74503072 |
| 19 | Gingivitis (HP:0000230) | 3.70619648 |
| 20 | * Increased cerebral lipofuscin (HP:0011813) | 3.46159966 |
| 21 | Glomerulonephritis (HP:0000099) | 3.40158838 |
| 22 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37121929 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.36050397 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.36050397 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.36050397 |
| 26 | Pancreatic cysts (HP:0001737) | 3.30838042 |
| 27 | Orchitis (HP:0100796) | 3.26462748 |
| 28 | Cellulitis (HP:0100658) | 3.22867474 |
| 29 | Periodontitis (HP:0000704) | 3.22849504 |
| 30 | Recurrent viral infections (HP:0004429) | 3.14935948 |
| 31 | Vasculitis (HP:0002633) | 3.11377353 |
| 32 | IgM deficiency (HP:0002850) | 3.10523682 |
| 33 | Axonal loss (HP:0003447) | 3.09781035 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.05104271 |
| 35 | Optic neuritis (HP:0100653) | 3.05104271 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.02811915 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 3.02459387 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 3.02459387 |
| 39 | Petechiae (HP:0000967) | 3.00882830 |
| 40 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97989969 |
| 41 | Type II lissencephaly (HP:0007260) | 2.96243052 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.86530947 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81711930 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81711930 |
| 45 | Chronic otitis media (HP:0000389) | 2.80991980 |
| 46 | Agnosia (HP:0010524) | 2.80919137 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.77769458 |
| 48 | Urticaria (HP:0001025) | 2.77629791 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.76555107 |
| 50 | Meningitis (HP:0001287) | 2.74347496 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.73944820 |
| 52 | Concave nail (HP:0001598) | 2.71168245 |
| 53 | Leukocytosis (HP:0001974) | 2.70065664 |
| 54 | Encephalitis (HP:0002383) | 2.69079575 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.67069676 |
| 56 | True hermaphroditism (HP:0010459) | 2.63583559 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.63225330 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.61021187 |
| 59 | Abnormality of alanine metabolism (HP:0010916) | 2.61021187 |
| 60 | Hyperalaninemia (HP:0003348) | 2.61021187 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.60765754 |
| 62 | Clumsiness (HP:0002312) | 2.59917215 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.57816617 |
| 64 | Loss of speech (HP:0002371) | 2.57155173 |
| 65 | Thick nail (HP:0001805) | 2.56817037 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.52505426 |
| 67 | Osteomyelitis (HP:0002754) | 2.51875410 |
| 68 | Premature loss of primary teeth (HP:0006323) | 2.49948826 |
| 69 | Disinhibition (HP:0000734) | 2.49476399 |
| 70 | Gingival bleeding (HP:0000225) | 2.46914092 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.44014626 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.42451329 |
| 73 | Hyperventilation (HP:0002883) | 2.41116846 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.40582163 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.39797809 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.37688931 |
| 77 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.37224269 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.35790855 |
| 79 | Polydipsia (HP:0001959) | 2.35653700 |
| 80 | Abnormal drinking behavior (HP:0030082) | 2.35653700 |
| 81 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33942473 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.32039983 |
| 83 | Epistaxis (HP:0000421) | 2.32031805 |
| 84 | Eosinophilia (HP:0001880) | 2.28433075 |
| 85 | Nephronophthisis (HP:0000090) | 2.27179515 |
| 86 | Cerebellar dysplasia (HP:0007033) | 2.26681324 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.26499969 |
| 88 | Large for gestational age (HP:0001520) | 2.26168799 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.24804093 |
| 90 | Increased serum ferritin (HP:0003281) | 2.21571279 |
| 91 | Tubular atrophy (HP:0000092) | 2.20916781 |
| 92 | Cheilitis (HP:0100825) | 2.18866943 |
| 93 | Nephritis (HP:0000123) | 2.17752452 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.17559387 |
| 95 | Reticulocytopenia (HP:0001896) | 2.17060924 |
| 96 | Albinism (HP:0001022) | 2.15475797 |
| 97 | Bile duct proliferation (HP:0001408) | 2.15339612 |
| 98 | Abnormal biliary tract physiology (HP:0012439) | 2.15339612 |
| 99 | Amelogenesis imperfecta (HP:0000705) | 2.14706870 |
| 100 | T lymphocytopenia (HP:0005403) | 2.14033396 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13428003 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13428003 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13428003 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13290703 |
| 105 | Mucopolysacchariduria (HP:0008155) | 2.13290703 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.13100835 |
| 107 | Granulocytopenia (HP:0001913) | 2.12592345 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.12386920 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 2.12121064 |
| 110 | Keratoconjunctivitis (HP:0001096) | 2.11206043 |
| 111 | Mesangial abnormality (HP:0001966) | 2.10045670 |
| 112 | Cystic liver disease (HP:0006706) | 2.09966140 |
| 113 | Increased IgM level (HP:0003496) | 2.09173787 |
| 114 | Colitis (HP:0002583) | 2.08929014 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06017894 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 2.05525804 |
| 117 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02985599 |
| 118 | Abnormality of the renal medulla (HP:0100957) | 2.01779897 |
| 119 | Alkalosis (HP:0001948) | 2.01531787 |
| 120 | Abnormality of T cells (HP:0002843) | 2.00873522 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 1.99958247 |
| 122 | Retinal atrophy (HP:0001105) | 1.99409833 |
| 123 | Leukopenia (HP:0001882) | 1.99237246 |
| 124 | Lymphopenia (HP:0001888) | 1.96376360 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.96022863 |
| 126 | * Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95062274 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.94484445 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94484445 |
| 129 | IgG deficiency (HP:0004315) | 1.94363938 |
| 130 | Parakeratosis (HP:0001036) | 1.94210950 |
| 131 | Keratoconjunctivitis sicca (HP:0001097) | 1.94205742 |
| 132 | Severe muscular hypotonia (HP:0006829) | 1.93868141 |
| 133 | Pathologic fracture (HP:0002756) | 1.93385273 |
| 134 | Purpura (HP:0000979) | 1.92820016 |
| 135 | Thrombocytosis (HP:0001894) | 1.92716031 |
| 136 | Genetic anticipation (HP:0003743) | 1.92565252 |
| 137 | Hemoptysis (HP:0002105) | 1.91802227 |
| 138 | Ketosis (HP:0001946) | 1.90916174 |
| 139 | Abnormality of T cell number (HP:0011839) | 1.90776320 |
| 140 | Stomach cancer (HP:0012126) | 1.90617320 |
| 141 | Joint hemorrhage (HP:0005261) | 1.90158052 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89395760 |
| 143 | Increased IgE level (HP:0003212) | 1.88921536 |
| 144 | Polyuria (HP:0000103) | 1.88662588 |
| 145 | Abnormality of male internal genitalia (HP:0000022) | 1.88034051 |
| 146 | Decreased central vision (HP:0007663) | 1.87243115 |
| 147 | Hypochromic anemia (HP:0001931) | 1.87215938 |
| 148 | * Abolished electroretinogram (ERG) (HP:0000550) | 1.84862999 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82550689 |
| 150 | Gastrointestinal infarctions (HP:0005244) | 1.82534762 |
| 151 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81303351 |
| 152 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81082269 |
| 153 | Autoimmune hemolytic anemia (HP:0001890) | 1.74694485 |
| 154 | Lissencephaly (HP:0001339) | 1.73009594 |
| 155 | Flat capital femoral epiphysis (HP:0003370) | 1.72938747 |
| 156 | Protruding tongue (HP:0010808) | 1.71252799 |
| 157 | Agitation (HP:0000713) | 1.69340818 |
| 158 | Cerebral palsy (HP:0100021) | 1.68193968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.06730278 |
| 2 | BLK | 4.04331125 |
| 3 | MAP3K14 | 3.68007784 |
| 4 | IRAK3 | 3.66942513 |
| 5 | IRAK4 | 3.45215480 |
| 6 | MAP4K1 | 3.37059601 |
| 7 | KIT | 3.29086392 |
| 8 | RIPK4 | 3.20032135 |
| 9 | ACVR1B | 2.87991264 |
| 10 | TXK | 2.71718221 |
| 11 | TYK2 | 2.71108626 |
| 12 | IKBKE | 2.66757230 |
| 13 | TBK1 | 2.65789280 |
| 14 | TLK1 | 2.50351319 |
| 15 | WNK4 | 2.34641505 |
| 16 | TAOK3 | 2.21510250 |
| 17 | PIK3CG | 2.19015580 |
| 18 | JAK3 | 2.18576570 |
| 19 | IKBKB | 2.18359904 |
| 20 | GRK1 | 2.09035682 |
| 21 | BTK | 2.03023461 |
| 22 | ZAP70 | 1.96447538 |
| 23 | EPHB1 | 1.94649148 |
| 24 | ZAK | 1.76267543 |
| 25 | NME2 | 1.76220782 |
| 26 | MAPKAPK3 | 1.71746725 |
| 27 | CSK | 1.70866302 |
| 28 | CSF1R | 1.70143618 |
| 29 | TNK2 | 1.69642625 |
| 30 | TEC | 1.64724623 |
| 31 | JAK1 | 1.61749163 |
| 32 | INSRR | 1.60620476 |
| 33 | HCK | 1.52631710 |
| 34 | LCK | 1.50030690 |
| 35 | MAP2K6 | 1.49296906 |
| 36 | PIM2 | 1.48500974 |
| 37 | NUAK1 | 1.46215844 |
| 38 | SYK | 1.44815552 |
| 39 | LYN | 1.43057222 |
| 40 | DAPK2 | 1.42441952 |
| 41 | MST4 | 1.42339508 |
| 42 | BCKDK | 1.41049930 |
| 43 | MATK | 1.36168912 |
| 44 | CLK1 | 1.33919307 |
| 45 | YES1 | 1.31498229 |
| 46 | PBK | 1.29344630 |
| 47 | ERN1 | 1.26548515 |
| 48 | FGR | 1.25021337 |
| 49 | OXSR1 | 1.23095631 |
| 50 | MAP4K2 | 1.22749926 |
| 51 | CAMKK2 | 1.22526425 |
| 52 | CHUK | 1.21869017 |
| 53 | ADRBK1 | 1.16749245 |
| 54 | TESK2 | 1.11216222 |
| 55 | PIM1 | 1.08161105 |
| 56 | TGFBR2 | 1.07501895 |
| 57 | MAPK13 | 1.06090484 |
| 58 | FES | 1.05343797 |
| 59 | MAP3K13 | 1.01306269 |
| 60 | ITK | 0.99416819 |
| 61 | MAP2K3 | 0.97144728 |
| 62 | STK10 | 0.96130913 |
| 63 | EIF2AK2 | 0.95077811 |
| 64 | STK39 | 0.94362720 |
| 65 | PINK1 | 0.94208871 |
| 66 | PIK3CA | 0.90237416 |
| 67 | PRKD2 | 0.86764032 |
| 68 | WNK3 | 0.84180493 |
| 69 | GRK7 | 0.83507216 |
| 70 | TRPM7 | 0.79793468 |
| 71 | BMPR1B | 0.78828558 |
| 72 | TAOK1 | 0.78618842 |
| 73 | FLT3 | 0.78463325 |
| 74 | TGFBR1 | 0.75515112 |
| 75 | ADRBK2 | 0.73770498 |
| 76 | JAK2 | 0.73079693 |
| 77 | IRAK1 | 0.71919914 |
| 78 | NME1 | 0.71715713 |
| 79 | FGFR4 | 0.71635641 |
| 80 | EPHA3 | 0.70383338 |
| 81 | PTK2B | 0.69690195 |
| 82 | NEK9 | 0.66228667 |
| 83 | MAPK11 | 0.65614380 |
| 84 | KDR | 0.65035230 |
| 85 | MAP3K7 | 0.63894093 |
| 86 | NLK | 0.63349818 |
| 87 | PRKAA2 | 0.63020354 |
| 88 | STK4 | 0.62783238 |
| 89 | RPS6KA4 | 0.59869673 |
| 90 | MARK3 | 0.55393157 |
| 91 | PRKCD | 0.55357298 |
| 92 | EGFR | 0.53914293 |
| 93 | MAP3K3 | 0.51855971 |
| 94 | ABL1 | 0.49013043 |
| 95 | MAP3K10 | 0.48011572 |
| 96 | MAP3K11 | 0.45933481 |
| 97 | CAMKK1 | 0.44956395 |
| 98 | PRKCI | 0.43876261 |
| 99 | STK11 | 0.41818528 |
| 100 | CDK6 | 0.41589067 |
| 101 | FGFR3 | 0.41472224 |
| 102 | IRAK2 | 0.41462252 |
| 103 | MAPKAPK5 | 0.40568694 |
| 104 | SIK3 | 0.40448353 |
| 105 | RPS6KA6 | 0.40314531 |
| 106 | CAMK1D | 0.39501543 |
| 107 | SIK2 | 0.36124206 |
| 108 | STK38 | 0.35496761 |
| 109 | MAPKAPK2 | 0.34926905 |
| 110 | PLK4 | 0.34476826 |
| 111 | PTK6 | 0.34388733 |
| 112 | PAK4 | 0.33431491 |
| 113 | PDGFRB | 0.33384967 |
| 114 | RPS6KA5 | 0.33034475 |
| 115 | ABL2 | 0.32626596 |
| 116 | TAOK2 | 0.32397464 |
| 117 | PRKCZ | 0.32383375 |
| 118 | DAPK3 | 0.31145940 |
| 119 | MAPK15 | 0.31144705 |
| 120 | VRK1 | 0.30645854 |
| 121 | BMPR2 | 0.29277248 |
| 122 | STK16 | 0.28840200 |
| 123 | PRKCG | 0.28289408 |
| 124 | PRKCA | 0.27837080 |
| 125 | MAP2K2 | 0.27289839 |
| 126 | MUSK | 0.27053458 |
| 127 | GRK6 | 0.26921605 |
| 128 | RPS6KL1 | 0.26893018 |
| 129 | RPS6KC1 | 0.26893018 |
| 130 | MAPK7 | 0.26566244 |
| 131 | CDC42BPA | 0.26349400 |
| 132 | CDK12 | 0.26075749 |
| 133 | PRKG2 | 0.25716943 |
| 134 | HIPK2 | 0.25316123 |
| 135 | PRKCQ | 0.25002396 |
| 136 | FYN | 0.24448623 |
| 137 | PRPF4B | 0.23559180 |
| 138 | PDK1 | 0.23393485 |
| 139 | MAPK4 | 0.23318805 |
| 140 | IGF1R | 0.23232742 |
| 141 | MAPK3 | 0.22675493 |
| 142 | DYRK3 | 0.22605584 |
| 143 | PDPK1 | 0.21666632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.40809362 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94850531 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63027287 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52897749 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.50990460 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.46791460 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41124350 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35568992 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.29723031 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19362550 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17165119 |
| 12 | * Lysosome_Homo sapiens_hsa04142 | 2.16742771 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12924253 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.07348923 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06147734 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05515681 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.02600508 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99781089 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97778863 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.88817149 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86524534 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.86225565 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.86141001 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83007459 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78084808 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.77696708 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77129071 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76418146 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73598622 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.67364200 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66289413 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65910270 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65601723 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.61250379 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61117333 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45849209 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44506342 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43022536 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42910501 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42366175 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42282955 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40784938 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40522131 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.38402236 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33879073 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.33473355 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30941745 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.29115708 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24833446 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.23851226 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.21801611 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21448071 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20788912 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20293272 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19387439 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.18736961 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16297448 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15686833 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12521544 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09033078 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08693565 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06066045 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 1.04021265 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99450029 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.98634498 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96684380 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96596436 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96363141 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96203530 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90326524 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88358882 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85786175 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85165341 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85083707 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83475843 |
| 76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83027421 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81901192 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81505108 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81341829 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79136891 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78412122 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74665855 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74220759 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.73495159 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71995720 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69939668 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69415545 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.69364811 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67945155 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67224116 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66492796 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65517146 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65342222 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65203498 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64590067 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64028579 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.63706896 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62062172 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61167095 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59267201 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58950087 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56880859 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56176795 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56124014 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56044530 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55974079 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54600676 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51520403 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51509228 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51232849 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.50877429 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48553806 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48413754 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48402505 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46301633 |
| 116 | Base excision repair_Homo sapiens_hsa03410 | 0.45567069 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45146605 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44659236 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44277614 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43433864 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42456056 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41779680 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41614285 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39920609 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.38227496 |
| 126 | Homologous recombination_Homo sapiens_hsa03440 | 0.37266489 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36836373 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33611230 |
| 129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32293991 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31791915 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30682018 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28935523 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28559783 |
| 134 | RNA polymerase_Homo sapiens_hsa03020 | 0.27620548 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27305079 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27240699 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.25340307 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.25281851 |
| 139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25016917 |

